Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Stock Quote

NASDAQCRDF
$1.52
NASDAQCRDF
Open
$1.53
Change
-$0.03 (-1.94%)
Day's Range
$1.48 - $1.54
52-Week Range
$1.13 - $3.41
Volume
235.5K
Market Cap
$67.9M